Abstract: The present invention relates to a crystal form IV of a compound represented by chemical formula 1, a preparation method therefor, and a pharmaceutical composition comprising same. The crystal form IV of a compound represented by chemical formula 1, of the present invention, can be specified by an XRD pattern, DSC profile and/or TGA profile.
| # | Name | Date |
|---|---|---|
| 1 | 202317030835-STATEMENT OF UNDERTAKING (FORM 3) [29-04-2023(online)].pdf | 2023-04-29 |
| 2 | 202317030835-REQUEST FOR EXAMINATION (FORM-18) [29-04-2023(online)].pdf | 2023-04-29 |
| 3 | 202317030835-FORM 18 [29-04-2023(online)].pdf | 2023-04-29 |
| 4 | 202317030835-FORM 1 [29-04-2023(online)].pdf | 2023-04-29 |
| 5 | 202317030835-DRAWINGS [29-04-2023(online)].pdf | 2023-04-29 |
| 6 | 202317030835-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2023(online)].pdf | 2023-04-29 |
| 7 | 202317030835-COMPLETE SPECIFICATION [29-04-2023(online)].pdf | 2023-04-29 |
| 8 | 202317030835.pdf | 2023-05-03 |
| 9 | 202317030835-Proof of Right [31-05-2023(online)].pdf | 2023-05-31 |
| 10 | 202317030835-FORM-26 [19-07-2023(online)].pdf | 2023-07-19 |
| 11 | 202317030835-FORM 3 [04-10-2023(online)].pdf | 2023-10-04 |
| 12 | 202317030835-Certified Copy of Priority Document [10-10-2023(online)].pdf | 2023-10-10 |
| 13 | 202317030835-FER.pdf | 2025-03-27 |
| 14 | 202317030835-FORM 3 [28-04-2025(online)].pdf | 2025-04-28 |
| 15 | 202317030835-FORM 4 [23-09-2025(online)].pdf | 2025-09-23 |
| 1 | 202317030835_SearchStrategyNew_E_searchstrategy202317030835E_19-03-2025.pdf |